SGR-1505, an orally active MALT1 allosteric inhibitor, reduces MALT1 enzymatic activity and demonstrates anti-proliferative effects in both BTK inhibitor (BTKi)-sensitive and BTKi-resistant activated B cell-like diffuse large B cell lymphoma (ABC-DLBCL) cell lines. SGR-1505 is applicable for B-cell lymphoma research [1].
Molecular Weight:
481.79
CAS Number:
[2661481-41-8]
Formula:
C18H12ClF4N9O
Target:
MALT
T87386
* VAT and and shipping costs not included. Errors and price changes excepted